Status:
COMPLETED
The Effect of Omeprazole on the Pharmacokinetics of Dasatinib in Healthy Subjects
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Healthy
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to assess the effect of omeprazole on the pharmacokinetics of dasatinib in healthy subjects and to assess the safety and tolerability of a single dose of dasatinib before ...
Eligibility Criteria
Inclusion
- Healthy subjects as determined by medical history, physical examination, ECGs, and clinical laboratory determinations
Exclusion
- Women who are pregnant or breastfeeding
- Prior exposure to dasatinib
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT00655746
Start Date
April 1 2008
End Date
May 1 2008
Last Update
December 15 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bristol-Myers Squibb Clinical Pharmacology Unit
Hamilton, New Jersey, United States, 08690